• 2550 Citations
  • 24 Scopus h-Index
20002019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Yanyan Lou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Cancer Vaccines Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 2550 Citations
  • 24 Scopus h-Index
  • 36 Article
  • 3 Review article
  • 1 Editorial

Effects of age and immune landscape on outcome in HER2-positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) trials

Chumsri, S., Serie, D. J., Li, Z., Pogue-Geile, K. L., Soyano-Muller, A. E., Mashadi-Hossein, A., Warren, S., Lou, Y., Colon-Otero, G., Knutson, K. L., Perez, E. A., Moreno Aspitia, A. & Thompson, E. A., Jan 1 2019, In : Clinical Cancer Research. 25, 14, p. 4422-4430 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
adjuvant P40
B 31
Trastuzumab

Hypereosinophilia in a patient with metastatic non-small-cell lung cancer treated with antiprogrammed cell death 1 (anti-PD-1) therapy

Lou, Y., Marin-Acevedo, J. A., Vishnu, P., Manochakian, R., Dholaria, B., Soyano, A., Luo, Y., Zhang, Y. & Knutson, K. L., May 1 2019, In : Immunotherapy. 11, 7, p. 577-584 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Eosinophilia
Cell Death
Therapeutics
Eosinophils
1 Citation (Scopus)

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Duma, N., Abdel-Ghani, A., Yadav, S., Hoversten, K. P., Reed, C. T., Sitek, A. N., Enninga, E. A. L., Paludo, J., Aguilera, J. V., Leventakos, K., Lou, Y., Kottschade, L. A., Dong, H. M., Mansfield, A., Manochakian, R., Adjei, A. & Dronca, R. S., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Programmed Cell Death 1 Receptor
Non-Small Cell Lung Carcinoma
Sex Characteristics
Melanoma
Therapeutics
31 Citations (Scopus)

Cancer immunotherapy beyond immune checkpoint inhibitors

Marin-Acevedo, J. A., Soyano, A. E., Dholaria, B., Knutson, K. L. & Lou, Y., Jan 12 2018, In : Journal of Hematology and Oncology. 11, 1, 8.

Research output: Contribution to journalReview article

Immunotherapy
Immune System
Neoplasms
CD274 Antigen
Programmed Cell Death 1 Receptor
9 Citations (Scopus)

Comprehensive characterization of alternative polyadenylation in human cancer

Xiang, Y., Ye, Y., Lou, Y., Yang, Y., Cai, C., Zhang, Z., Mills, T., Chen, N. Y., Kim, Y., Ozguc, F. M., Diao, L., Karmouty-Quintana, H., Xia, Y., Kellems, R. E., Chen, Z., Blackburn, M. R., Yoo, S. H., Shyu, A. B., Mills, G. B. & Han, L., Apr 1 2018, In : Journal of the National Cancer Institute. 110, 4, p. 379-389 11 p.

Research output: Contribution to journalArticle

Polyadenylation
Neoplasms
Cell Line
mRNA Cleavage and Polyadenylation Factors
Pharmaceutical Preparations